Panacea Life Sciences Holdings, Inc. (PLSH): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-28, first reflected in a filing dated 2021-11-22. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

17.65M
As of 2023-12-31
+1.4%
3-year compound annual growth
43.82M2014-12-31: 15.14M2015-12-31: 515.3K2016-12-31: 34.07M2017-12-31: 4.38M2018-12-31: 6.23M2019-12-31: 43.82M2020-12-31: 16.92M2021-12-31: 14.07M2022-12-31: 14.97M2023-12-31: 17.65M17.65M
2014-12-31 Shares Outstanding (shares) 2023-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2023-12-3117.65M+17.9%2024-04-01, Balance as of period end
2022-12-3114.97M+6.3%2024-04-01, Balance as of period end
2021-12-3114.07M-16.8%2023-03-30, Balance as of period end
2020-12-3116.92Mn/c2022-03-31, Balance as of period end
2019-12-3143.82M+603.0%2021-04-23, Balance as of period end
2018-12-316.23M+42.2%2020-05-22, Balance as of period end
2017-12-314.38M-87.1%2019-03-29, Balance as of period end
2016-12-3134.07Mn/m2018-04-02, Balance as of period end
2015-12-31515.3K-96.6%2017-03-31, Balance as of period end
2014-12-3115.14Mn/a2016-02-29, Balance as of period end